Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Gastrointest Endosc. 2020 Jan 15;92(1):31–39.e1. doi: 10.1016/j.gie.2020.01.013

Table 2:

Outcome Summaries

Surgical group N=68 Endoscopic group N=73
Follow-up (months) median, [IQR] 49.4 [21.8–82.7] 43.4 [12.8–79.2]
Follow-up (person years) 287.8 189.1
Total number of deaths 14 34
Overall mortality (incidence rate) 4.9 per 100 person years 18.0 per 100 person years
Causes of death (n, % of deaths)
 Unknown causes 6 (42.9%) 23 (67.6%)
 Esophageal cancer related 4 (28.6%) 4 (11.8%)
 Cardiopulmonary 1 (7.1%) 6 (17.6%)
 Surgical adverse events 2 (14.3%) 0 (0%)
 Nonesophageal cancer 1 (7.1%) 1 (3.0%)
Number of recurrent cancers / Number achieving remission 4 / 68 6 / 46
Follow-up after remission (person years) 277.4 89.5
Recurrent carcinoma (incidence rate) 1.4 per 100 person years 6.7 per 100 person years

IQR = interquartile range